HPV vaccination has been advocated for the prevention of cervical cancer, its application in preventing oropharyngeal cancers is being recognized.
MedGenome
Rare Disease Day 2025: Lifesaving campaign launched by MedGenome
MedGenome, a global leader in genomics-driven diagnostics and research services, launched its campaign, #CarefortheRare, ahead of Rare Disease Day.
How early screening for rare chromosomal issues could impact pregnancy?
While humans typically have 23 pairs of chromosomes, abnormalities can result in an excess or shortage of chromosomes and structural issues such as deletions, duplications, or translocations.
MedGenome invests in GenX Diagnostics lab
Expands presence in East India with GenX Diagnostics stake acquisition
MedGenome acquires NovaSeq X Plus
MedGenome acquires Illumina’s NovaSeq X Plus and launches KaryoSeq for genome sequencing.
MedGenome launches VarMiner to detect genetic variants for rare diseases and inherited cancers
The novel Machine Learning based analysis software can accurately predict and rank a pathogenic variant in 90% of rare diseases cases with no or minimum manual intervention
MedGenome announces leadership transitions
Co‐Founder Sam Santhosh steps down as Chairman and Group CEO
ACE2 gene mutations predict COVID-19 susceptibility
ACE2, an enzyme created by the ACE2 protein, usually plays a role in the maintenance of blood pressure but is tricked by the virus into becoming an entrance
Medgenome announces $55m investment led by LeapFrog
The investment will expand access and affordability of genetic testing services across India
IMMUCARE, India’s first exclusive diagnostic lab for autoimmune diseases, launched in Kochi
The center of excellence has a strong focus on research in autoimmune diseases